Literature DB >> 32499373

FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model.

Haruko Miyazaki1,2,3,4, Tomoyuki Yamanaka1,2,3,4, Fumitaka Oyama2,5, Yoshihiro Kino2,6, Masaru Kurosawa2,7, Mizuki Yamada-Kurosawa2, Risa Yamano1, Tomomi Shimogori3, Nobutaka Hattori8, Nobuyuki Nukina9,2,3,4.   

Abstract

Huntington disease (HD) is a neurodegenerative disorder caused by expanded CAG repeats in the Huntingtin gene. Results from previous studies have suggested that transcriptional dysregulation is one of the key mechanisms underlying striatal medium spiny neuron (MSN) degeneration in HD. However, some of the critical genes involved in HD etiology or pathology could be masked in a common expression profiling assay because of contamination with non-MSN cells. To gain insight into the MSN-specific gene expression changes in presymptomatic R6/2 mice, a common HD mouse model, here we used a transgenic fluorescent protein marker of MSNs for purification via FACS before profiling gene expression with gene microarrays and compared the results of this "FACS-array" with those obtained with homogenized striatal samples (STR-array). We identified hundreds of differentially expressed genes (DEGs) and enhanced detection of MSN-specific DEGs by comparing the results of the FACS-array with those of the STR-array. The gene sets obtained included genes ubiquitously expressed in both MSNs and non-MSN cells of the brain and associated with transcriptional regulation and DNA damage responses. We proposed that the comparative gene expression approach using the FACS-array may be useful for uncovering the gene cascades affected in MSNs during HD pathogenesis.
© 2020 Miyazaki et al.

Entities:  

Keywords:  DNA damage; Huntington disease; R6/2 mouse model; fluorescence-activated cell sorting (FACS); medium spiny neuron (MSN); microarray; neurodegeneration; striatum; transcription regulation; transcriptomics

Mesh:

Substances:

Year:  2020        PMID: 32499373      PMCID: PMC7380199          DOI: 10.1074/jbc.RA120.012983

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

Authors:  C A Gutekunst; S H Li; H Yi; J S Mulroy; S Kuemmerle; R Jones; D Rye; R J Ferrante; S M Hersch; X J Li
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation.

Authors:  Mee-Ohk Kim; Prianka Chawla; Ryan P Overland; Eva Xia; Ghazaleh Sadri-Vakili; Jang-Ho J Cha
Journal:  J Neurosci       Date:  2008-04-09       Impact factor: 6.167

Review 3.  What have we learned from gene expression profiles in Huntington's disease?

Authors:  Tamara Seredenina; Ruth Luthi-Carter
Journal:  Neurobiol Dis       Date:  2011-07-12       Impact factor: 5.996

4.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.

Authors:  Paula A Desplats; Kristi E Kass; Tim Gilmartin; Gregg D Stanwood; Elliott L Woodward; Steven R Head; J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  J Neurochem       Date:  2006-01-09       Impact factor: 5.372

7.  Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor.

Authors:  Tomoyuki Yamanaka; Haruko Miyazaki; Fumitaka Oyama; Masaru Kurosawa; Chika Washizu; Hiroshi Doi; Nobuyuki Nukina
Journal:  EMBO J       Date:  2008-02-21       Impact factor: 11.598

8.  Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice.

Authors:  Christopher A Meade; Yun-Ping Deng; Francesca R Fusco; Nobel Del Mar; Steven Hersch; Dan Goldowitz; Anton Reiner
Journal:  J Comp Neurol       Date:  2002-07-29       Impact factor: 3.215

9.  Huntington's Disease and Striatal Signaling.

Authors:  Emmanuel Roze; Emma Cahill; Elodie Martin; Cecilia Bonnet; Peter Vanhoutte; Sandrine Betuing; Jocelyne Caboche
Journal:  Front Neuroanat       Date:  2011-08-23       Impact factor: 3.856

Review 10.  Uncoupling protein 2 in the glial response to stress: implications for neuroprotection.

Authors:  Daniel T Hass; Colin J Barnstable
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

View more
  3 in total

1.  Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y.

Authors:  Tomoyuki Yamanaka; Haruko Miyazaki; Asako Tosaki; Sankar N Maity; Tomomi Shimogori; Nobutaka Hattori; Nobuyuki Nukina
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 2.  What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Authors:  Jasmine Donaldson; Sophie Powell; Nadia Rickards; Peter Holmans; Lesley Jones
Journal:  J Huntingtons Dis       Date:  2021

Review 3.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.